Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes
Titel:
Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes
Auteur:
Proietto, Joseph Lau, David C.W. Fujioka, Ken Greenway, Frank O’Neil, Patrick Wilding, John P.H. Jacobsen, Peter B. Skjøth, Trine V. Madsbad, Sten O’Moore-Sullivan, Trisha